Pharmaceutical conglomerate Merck has been issued a fine of $1.8 million by Brazilian antitrust authorities for engaging in pay-for-delay agreements.
Antitrust regulator CADE lodged the fine in response to Merck’s attendance at a meeting joined by top rivals Bayer, Abbott Laboratories, Bristol-Myers, Eli Lilly, Johnson & Johnson, Roche and more, say …read more
Source: Global Competition Law Blogs